ST
Spiral Therapeutics Inc
SEC filingPharmaceuticals · South San Francisco, CA
Amount raised$27.1Msold at filing
Total offering$27.1M$3 still open
Investors in the raise34count reported to the SEC
FiledApr 16, 2026first sale Sep 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
WARREN THALERDirector
EUGENE DE JUANExecutive Officer, Director
ANTHONY ADAMISDirector
FREDERIC GUERARDDirector
JEAN-FREDERIC PAULSENDirector
GUY JEAN SAVOIR GARCIADirector
HUGO PERISExecutive Officer, Director
DIAMANTIS XYLASDirector
ANGELA MACFARLANEDirector
Executive officers, directors and promoters as listed on the Form D.